Choosing the right indication, patient and dose: AI in action for CNS drugs
Dec 3, 2026 | 2:45 PM - 3:00 PMStartup Stage
Dec 3, 2026 | 2:45 PM - 3:00 PM
Startup Stage
Description
Why do so many CNS drugs fail, and how can AI change that? Iris Maréchal, CEO and co-founder of Theremia, shares how her team uses patient and pharmacological data with AI to choose the right indication, the right patients and the right dose. Expect real use cases from neurodegenerative diseases such as Parkinson’s, ALS and Alzheimer’s.



